EPO Board of Appeal OKs Agennix Patent Claims
The European Patent Office's Technical Board of Appeal has decided in favor of Agennix in litigation over its European patent covering the cDNA sequence and expression of recombinant human lactoferrin (rhLF),...To view the full article, register now.
Already a subscriber? Click here to view full article